Serina Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $5.2M | $-15.0M | $1.1M | $1.8M | $808.0K | $1.7M | $-2.7M | $-2.4M |
| Depreciation & Amortization | $57.0K | $25.0K | $6.0K | $54.0K | $17.0K | $13.0K | — | — |
| Depreciation | $0 | $23.0K | — | — | $18.0K | $13.0K | — | — |
| Amortization | $33.0K | $2.0K | $33.0K | $33.0K | $32.0K | $33.0K | $33.0K | $33.0K |
| Stock-Based Compensation | $458.0K | $53.0K | $0 | $0 | $23.0K | $2.0K | $114.0K | $209.0K |
| Net Cash from Operating Activities | $-8.0M | $-1.6M | $121.0K | $-1.0M | $-864.0K | $-709.0K | $-1.3M | $-1.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $14.0K | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $-14.0K | $-70.0K | $-119.0K | $9.7M | $-10.0M | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $5.4M | $2.7M | $-13.0K | $2.0K | $-11.0K | $10.1M | $1.5M | $1.0M |
| Net Change in Cash | $-2.6M | $1.1M | $38.0K | $-1.1M | $-1.2M | $9.4M | $179.0K | $-236.0K |
| Free Cash Flow | $-8.0M | $-1.6M | — | — | — | — | — | — |